Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Nunn

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Current Opinion in Pulmonary Medicine|March 27, 2013
Treatment of pulmonary tuberculosisAndrew Nunn, Patrick P J Phillips, Ibrahim Abubakar
Topics in Spinal Cord Injury Rehabilitation|November 22, 2018
Experiences With Navigating and Managing Information in the Community Following Spinal Cord InjuryAlyse Lennox, Belinda Gabbe, Andrew Nunn, et al.
The American Surgeon|May 26, 2019
Delayed Closure Is Associated with Decreased Infection Rate in Amputations after TraumaYasmin Ali, Jason Halvorson, Andrew Nunn, et al.
BMJ (Clinical Research Ed.)|March 4, 2006
Intrapleural streptokinase for pleural infectionNick Maskell, Andrew Nunn, Robert J O Davies
ANZ Journal of Surgery|October 26, 2011
Direct diaphragm pacing stimulationMehrdad Nikfarjam, David A Story, Andrew Nunn, et al.
Nature Reviews. Drug Discovery|March 2, 2012
Advancing the development of tuberculosis therapyAlimuddin Zumla, Richard Hafner, Christian Lienhardt, et al.
Disability and Rehabilitation|April 15, 2017
Experiences of hospital readmission and receiving formal carer services following spinal cord injury: a qualitative study to identify needsSandra C Braaf, Alyse Lennox, Andrew Nunn, et al.
The Lancet. Respiratory Medicine|August 21, 2019
Individualising therapy for drug-sensitive tuberculosisHanif Esmail, Marc C Lipman, Andrew Nunn, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Reasons for participating in a randomised clinical trial: The volunteers' voices in the COSTOP trial in UgandaAgnes Ssali, Andrew Nunn, Martin Mbonye, et al.
Trials|October 29, 2009
Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV preventionAndrew Nunn, Sheena McCormack, Angela M Crook, et al.
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Current Opinion in Pulmonary Medicine|March 27, 2013
Treatment of pulmonary tuberculosisAndrew Nunn, Patrick P J Phillips, Ibrahim Abubakar
Topics in Spinal Cord Injury Rehabilitation|November 22, 2018
Experiences With Navigating and Managing Information in the Community Following Spinal Cord InjuryAlyse Lennox, Belinda Gabbe, Andrew Nunn, et al.
The American Surgeon|May 26, 2019
Delayed Closure Is Associated with Decreased Infection Rate in Amputations after TraumaYasmin Ali, Jason Halvorson, Andrew Nunn, et al.
BMJ (Clinical Research Ed.)|March 4, 2006
Intrapleural streptokinase for pleural infectionNick Maskell, Andrew Nunn, Robert J O Davies
ANZ Journal of Surgery|October 26, 2011
Direct diaphragm pacing stimulationMehrdad Nikfarjam, David A Story, Andrew Nunn, et al.
Nature Reviews. Drug Discovery|March 2, 2012
Advancing the development of tuberculosis therapyAlimuddin Zumla, Richard Hafner, Christian Lienhardt, et al.
Disability and Rehabilitation|April 15, 2017
Experiences of hospital readmission and receiving formal carer services following spinal cord injury: a qualitative study to identify needsSandra C Braaf, Alyse Lennox, Andrew Nunn, et al.
The Lancet. Respiratory Medicine|August 21, 2019
Individualising therapy for drug-sensitive tuberculosisHanif Esmail, Marc C Lipman, Andrew Nunn, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Reasons for participating in a randomised clinical trial: The volunteers' voices in the COSTOP trial in UgandaAgnes Ssali, Andrew Nunn, Martin Mbonye, et al.
Trials|October 29, 2009
Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV preventionAndrew Nunn, Sheena McCormack, Angela M Crook, et al.
Pageof 11